Alli (AL-eye), the OTC version of orlistat just approved for weight loss in adults

March 2007

There's a lot of buzz about Alli (AL-eye), the OTC version of orlistat just approved for weight loss in adults.

It'll be on store shelves this summer and cost about $2 a day.

Alli is half the strength of Xenical...but expect similar efficacy and side effects.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

huge new step toward electronic prescribing with the launch of a new program called eRx Now
Infectious Diseases recommendations for treating community-acquired pneumonia in adults
Women's Health whether the newer low-dose oral contraceptives are less effective
Supplements People are asking if they should take MORE vitamin D and LESS calcium
Cardiology Coreg CR, a new extended-release carvedilol
Cardiology new antihypertensive called Tekturna, the first direct renin inhibitor
Gastroenterology both a proton pump inhibitor PLUS an H2-blocker for GERD
Gastroenterology Lialda (lee-AL-duh) is the first ONCE-daily oral mesalamine for ulcerative colitis
Kidney Disease minimize the risk of kidney damage due to the contrast dyes used for diagnostic tests
OTC Products Alli (AL-eye), the OTC version of orlistat just approved for weight loss in adults
OTC Products OTC brand name product extensions continue to cause confusion
if their meds can cause weight gain
MTM using the new pharmacist-specific CPT codes to get paid for Medication Therapy Management (MTM)